Gallinée Appoints Romain Carrega to Lead Its European Expansion

Why It Matters

The appointment accelerates Gallinée’s shift from a digital‑first model to an omnichannel strategy, positioning the brand to capture growing consumer demand for scientifically backed microbiome products across Europe.

Key Takeaways

• Romain Carrega joins Gallinée to drive European growth
• Pharmacy presence expanded tenfold to 450 locations
• Total active points of sale exceed 1,250 across Europe
• Shift from digital‑first to omnichannel brand building
• Microbiome focus aligns with Shiseido’s innovation agenda

Pulse Analysis

The microbiome skincare market is entering a phase of rapid maturation, as consumers increasingly seek products backed by scientific research. Gallinée, acquired by Shiseido in 2022, has leveraged the parent company’s R&D capabilities to position itself as a laboratory for microbiome innovation. This strategic emphasis differentiates the brand in a crowded beauty landscape, where claims of skin health often lack rigorous validation, and it resonates with a growing segment of health‑conscious shoppers.

Romain Carrega’s appointment signals a decisive pivot toward an omnichannel growth model. With a track record of scaling prestige brands for Shiseido and L’Oréal across EMEA and Asia‑Pacific, Carrega brings deep expertise in aligning product narratives with retail execution. Under his leadership, Gallinée will integrate global communications, digital initiatives, and trade marketing to amplify its presence beyond e‑commerce, capitalising on the tenfold increase in pharmacy placements that now anchor the brand’s European distribution.

Industry observers view Gallinée’s European push as a bellwether for the broader beauty sector’s embrace of science‑driven categories. By marrying microbiome research with professional recommendation channels, the brand can command premium pricing and foster loyalty among dermatology‑aware consumers. If successful, Gallinée’s model could inspire other legacy beauty houses to invest in niche scientific platforms, reshaping competitive dynamics and accelerating innovation pipelines across the continent.